In this work, we propose an advanced AI based grading system for OCT images. The proposed system is a very deep fully convolutional attentive classification network trained with end to end advanced transfer learning with online random augmentation. It uses quasi random augmentation that outputs confidence values for diseases prevalence during inference. Its a fully automated retinal OCT analysis AI system capable of pathological lesions understanding without any offline preprocessing postprocessing step or manual feature extraction. We present a state of the art performance on the publicly available Mendeley OCT dataset.
Deep learning is successfully applied in many applications of the medical image analysis domain. Tasks related to features segmentation @cite_0 and feature classification @cite_7 can be performed using both traditional computer vision and deep learning. Deep learning recently captured momentum to outperform traditional features based methods used in the medical image domain. Starting from retinal analysis to cancer analysis, deep learning proved its usefulness as screening and diagnostic tools for doctors. In the eye @cite_8 and X-ray @cite_6 screening scenarios deep learning outperforms human practitioners.
@cite_0 @cite_6 @cite_7 @cite_8
2533800772 2311857205 2951965145 2806321514
This review covers computer-assisted analysis of images in the field of medical imaging. Recent advances in machine learning, especially with regard to deep learning, are helping to identify, classify, and quantify patterns in medical images. At the core of these advances is the ability to exploit hierarchical feature representations learned solely from data, instead of features designed by hand according to domain-specific knowledge. Deep learning is rapidly becoming the state of the art, leading to enhanced performance in various medical applications. We introduce the fundamentals of deep learning methods and review their successes in image registration, detection of anatomical and cellular structures, tissue segmentation, computer-aided disease diagnosis and prognosis, and so on. We conclude by discussing research issues and suggesting future directions for further improvement. Deep learning is considered as a popular and powerful method in pattern recognition and classification. However, there are not many deep structured applications used in medical imaging diagnosis area, because large dataset is not always available for medical images. In this study we tested the feasibility of using deep learning algorithms for lung cancer diagnosis with the cases from Lung Image Database Consortium (LIDC) database. The nodules on each computed tomography (CT) slice were segmented according to marks provided by the radiologists. After down sampling and rotating we acquired 174412 samples with 52 by 52 pixel each and the corresponding truth files. Three deep learning algorithms were designed and implemented, including Convolutional Neural Network (CNN), Deep Belief Networks (DBNs), Stacked Denoising Autoencoder (SDAE). To compare the performance of deep learning algorithms with traditional computer aided diagnosis (CADx) system, we designed a scheme with 28 image features and support vector machine. The accuracies of CNN, DBNs, and SDAE are 0.7976, 0.8119, and 0.7929, respectively; the accuracy of our designed traditional CADx is 0.7940, which is slightly lower than CNN and DBNs. We also noticed that the mislabeled nodules using DBNs are 4 larger than using traditional CADx, this might be resulting from down sampling process lost some size information of the nodules. Deep learning (DL) has revolutionized the field of computer vision and image processing. In medical imaging, algorithmic solutions based on DL have been shown to achieve high performance on tasks that previously required medical experts. However, DL-based solutions for disease detection have been proposed without methods to quantify and control their uncertainty in a decision. In contrast, a physician knows whether she is uncertain about a case and will consult more experienced colleagues if needed. Here we evaluate drop-out based Bayesian uncertainty measures for DL in diagnosing diabetic retinopathy (DR) from fundus images and show that it captures uncertainty better than straightforward alternatives. Furthermore, we show that uncertainty informed decision referral can improve diagnostic performance. Experiments across different networks, tasks and datasets show robust generalization. Depending on network capacity and task dataset difficulty, we surpass 85 sensitivity and 80 specificity as recommended by the NHS when referring 0−20 of the most uncertain decisions for further inspection. We analyse causes of uncertainty by relating intuitions from 2D visualizations to the high-dimensional image space. While uncertainty is sensitive to clinically relevant cases, sensitivity to unfamiliar data samples is task dependent, but can be rendered more robust. Deep learning algorithms require large amounts of labeled data which is difficult to attain for medical imaging. Even if a particular dataset is accessible, a learned classifier struggles to maintain the same level of performance on a different medical imaging dataset from a new or never-seen data source domain. Utilizing generative adversarial networks in a semi-supervised learning architecture, we address both problems of labeled data scarcity and data domain overfitting. For cardiac abnormality classification in chest X-rays, we demonstrate that an order of magnitude less data is required with semi-supervised learning generative adversarial networks than with conventional supervised learning convolutional neural networks. In addition, we demonstrate its robustness across different datasets for similar classification tasks.